check_circleStudy Completed

Magnetic Resonance Imaging

Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of CNS lesions in teenage patients (13-18 years) (phase III)

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

12 - 18 Years
  • -

  • -

Trial summary

Enrollment Goal
26
Trial Dates
September 1986 - December 1987
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of CNS lesions in teenage patients (13-18 years) (phase III)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A